Cargando…
Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events
BACKGROUND: The LATERAL trial validated the safety and efficacy of the thoracotomy approach for implantation of the HeartWare HVAD System, leading to Food and Drug Administration approval. We sought to analyze 24-month adverse event (AE) rates, including a temporal analysis of the risk profile, asso...
Autores principales: | Wieselthaler, Georg M., Klein, Liviu, Cheung, Anson W., Danter, Matthew R., Strueber, Martin, Mahr, Claudius, Mokadam, Nahush A., Maltais, Simon, McGee, Edwin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059760/ https://www.ncbi.nlm.nih.gov/pubmed/33866829 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.120.006912 |
Ejemplares similares
-
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device
por: Mahr, Claudius, et al.
Publicado: (2020) -
Reply: In pursuit of the unfilled position
por: Hwalek, Ann E., et al.
Publicado: (2020) -
Three-dimensional printing to plan intracardiac operations
por: Henn, Matthew C., et al.
Publicado: (2021) -
Intraoperative graft patency validation: Friend or foe?
por: Ganapathi, Asvin M., et al.
Publicado: (2021) -
Right ventricular dysfunction is best managed with a total artificial heart
por: Henn, Matthew C., et al.
Publicado: (2021)